Your browser doesn't support javascript.
loading
Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor.
Tahermanesh, Kobra; Hakimpour, Sahar; Govahi, Azam; Keyhanfar, Fariborz; Kashi, Abolfazl Mehdizadeh; Chaichian, Shahla; Shahriyaripour, Roya; Ajdary, Marziyeh.
Afiliación
  • Tahermanesh K; Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Hakimpour S; Department of Physiology, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
  • Govahi A; Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Keyhanfar F; Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Kashi AM; Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Chaichian S; Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Shahriyaripour R; Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Ajdary M; Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.
Biomed Res Int ; 2022: 1111777, 2022.
Article en En | MEDLINE | ID: mdl-36588534

Texto completo: 1 Colección: 01-internacional Asunto principal: Cannabidiol / Síndrome de Hiperestimulación Ovárica Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals Idioma: En Revista: Biomed Res Int Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Asunto principal: Cannabidiol / Síndrome de Hiperestimulación Ovárica Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals Idioma: En Revista: Biomed Res Int Año: 2022 Tipo del documento: Article País de afiliación: Irán